Claes Glassell has been appointed chief executive officer of CMC Biologics. Mr. Glassell joins the company from Cerus Corp., where he served as chief executive officer. Prior to that he was president of Cambrex Corp. Mr. Glassell joined the CMC board of directors in 2005. Previously, he held senior positions with Akzo Nobel NV, Nobel Industries AB and Berol Kemi AB. His areas of expertise include 20 years of executive positions in publicly listed life sciences companies responsible for bioproces...